<!DOCTYPE html>

<html lang="en" data-theme="light">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Oxytocin & Other Drugs Acting on Uterus - Essentials of Medical Pharmacology</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap"
        rel="stylesheet">

    <link rel="stylesheet" href="../styles/main.css">

    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\\(', '\\)']],
                displayMath: [['$$', '$$'], ['\\[', '\\]']],
                processEscapes: true,
                processEnvironments: true
            },
            svg: { fontCache: 'global' },
            options: {
                skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
            }
        };
    </script>

    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

</head>

<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Floating TOC -->

    <nav class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span> Table of Contents
        </div>
        <ul class="floating-toc-list">
            <li><a href="#uterine-stimulants">Uterine Stimulants</a></li>
            <li><a href="#oxytocin">Oxytocin</a></li>
            <li><a href="#oxytocin-uses">Clinical Uses of Oxytocin</a></li>
            <li><a href="#ergometrine">Ergometrine & Methylergometrine</a></li>
            <li><a href="#prostaglandins">Prostaglandins</a></li>
            <li><a href="#tocolytics">Uterine Relaxants (Tocolytics)</a></li>
            <li><a href="#case-study">Problem Directed Study</a></li>
        </ul>
    </nav>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üë∂</span>
                        <span>Topic 24</span>
                    </div>
                    <h1 class="document-title">Oxytocin and Other Drugs Acting on Uterus</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Hormones and Related Drugs</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>40 min read</span>
                        </div>
                    </div>
                </header>
                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Introduction -->
                    <section class="content-section" id="uterine-stimulants">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö°</span>
                                Uterine Stimulants (Oxytocics)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>These drugs increase uterine motility, especially at term. They are used for induction of
                                labour, uterine inertia, and control of postpartum haemorrhage.</p>
                            <p><strong>Major Classes:</strong></p>
                            <ul>
                                <li><strong>Posterior Pituitary Hormone:</strong> Oxytocin.</li>
                                <li><strong>Ergot Alkaloids:</strong> Ergometrine, Methylergometrine.</li>
                                <li><strong>Prostaglandins:</strong> $PGE_2$, $PGF_{2\alpha}$, Misoprostol.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 2: Oxytocin -->
                    <section class="content-section" id="oxytocin">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Oxytocin
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Oxytocin is a nonapeptide secreted by the posterior pituitary. It is synthesized in the
                                hypothalamus and transported down the axon to the neurohypophysis.</p>

                            <h3>Physiological Roles</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Labour:</strong> Released during labour; uterus is highly
                                    sensitive at term. Facilitates parturition.</li>
                                <li class="list-item"><strong>Milk Ejection Reflex:</strong> Suckling induces oxytocin
                                    release $\rightarrow$ contraction of myoepithelial cells of mammary alveoli
                                    $\rightarrow$ milk letdown.</li>
                            </ul>

                            <h3>Pharmacological Actions</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Uterus:</strong> Increases force and frequency of
                                    contractions. At low doses, full relaxation occurs between contractions (preserving
                                    foetal blood supply). Sensitivity increases sharply at term.</li>
                                <li class="list-item"><strong>CVS:</strong> High doses cause transient vasodilatation
                                    (fall in BP) and reflex tachycardia.</li>
                                <li class="list-item"><strong>Kidney:</strong> High doses have ADH-like antidiuretic
                                    action (risk of water intoxication).</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 3: Uses of Oxytocin -->
                    <section class="content-section" id="oxytocin-uses">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                Clinical Uses of Oxytocin
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Oxytocin is the <strong>drug of choice</strong> for induction and augmentation of labour.
                            </p>

                            <h3>1. Induction of Labour</h3>
                            <p><strong>Indication:</strong> Postmaturity, toxaemia, premature rupture of membranes, etc.
                            </p>
                            <p><strong>Method:</strong> Slow i.v. infusion. Start with low rate, increase progressively
                                until contractions are adequate. Monitoring of foetal heart rate and uterine
                                contractions is essential.</p>

                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">üõë</span>
                                    <h4 class="callout-title">Prerequisites & Contraindications</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Ensure: Presentation is correct, no cephalopelvic disproportion, no placenta
                                        previa, <strong>no foetal distress</strong>, and no previous uterine scar.</p>
                                </div>
                            </div>

                            <h3>2. Uterine Inertia</h3>
                            <p>To augment feeble contractions in cases of protracted labour (after ruling out
                                obstruction).</p>

                            <h3>3. Postpartum Haemorrhage (PPH)</h3>
                            <p>5 IU i.m. or i.v. infusion. Acts by contracting the uterus and compressing blood vessels.
                                Preferred over ergometrine in hypertensive women.</p>

                            <h3>4. Breast Engorgement</h3>
                            <p>Intranasal spray to elicit milk ejection reflex.</p>

                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Adverse Effects</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li><strong>Uterine Rupture:</strong> If used injudiciously or in obstructed
                                            labour.</li>
                                        <li><strong>Foetal Asphyxia:</strong> Due to strong contractions reducing
                                            placental blood flow.</li>
                                        <li><strong>Water Intoxication:</strong> With high doses + electrolyte-free
                                            fluids (due to ADH-like action).</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 4: Ergometrine -->
                    <section class="content-section" id="ergometrine">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üçÑ</span>
                                Ergometrine & Methylergometrine
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Amine ergot alkaloids. Methylergometrine is more potent.</p>

                            <h3>Actions</h3>
                            <p>Increases force, frequency, and duration of contractions. Unlike oxytocin, moderate doses
                                cause increased basal tone and <strong>sustained tetanic contraction</strong>
                                (contracture). This compresses uterine vessels effectively.</p>

                            <h3>Uses</h3>
                            <p><strong>Control/Prevention of PPH:</strong> 0.2 mg i.m. at the delivery of anterior
                                shoulder. Produces sustained contraction to arrest bleeding.</p>
                            <p><strong>Contraindicated:</strong> Before delivery of the foetus (can cause
                                asphyxia/uterine rupture) and in patients with hypertension/vascular disease (weak
                                vasoconstrictor action).</p>
                        </div>
                    </section>

                    <!-- Section 5: Prostaglandins -->
                    <section class="content-section" id="prostaglandins">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß™</span>
                                Prostaglandins
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>$PGE_2$ (Dinoprostone), $PGF_{2\alpha}$ (Carboprost), and Misoprostol ($PGE_1$ analogue).
                            </p>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Cervical Priming (Ripening):</strong> $PGE_2$ gel applied
                                    intracervically softens the cervix.</li>
                                <li class="list-item"><strong>Induction of Labour:</strong> Alternative to oxytocin.
                                </li>
                                <li class="list-item"><strong>Mid-trimester Abortion:</strong> Intra-amniotic or
                                    extra-amniotic injection.</li>
                                <li class="list-item"><strong>PPH:</strong> Carboprost ($PGF_{2\alpha}$) is used for
                                    refractory PPH.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 6: Tocolytics -->
                    <section class="content-section" id="tocolytics">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõë</span>
                                Uterine Relaxants (Tocolytics)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Drugs that decrease uterine motility. Used to <strong>delay premature labour</strong> (to
                                allow time for corticosteroid administration for foetal lung maturation).</p>

                            <h3>1. $\beta_2$ Adrenergic Agonists</h3>
                            <p><strong>Ritodrine, Isoxsuprine, Terbutaline.</strong></p>
                            <p><strong>Adverse Effects:</strong> Maternal tachycardia, hypotension, pulmonary edema,
                                hyperglycaemia, hypokalaemia.</p>

                            <h3>2. Calcium Channel Blockers</h3>
                            <p><strong>Nifedipine.</strong> Oral administration. Efficacy comparable to $\beta_2$
                                agonists with fewer side effects. Now often preferred.</p>

                            <h3>3. Oxytocin Antagonist</h3>
                            <p><strong>Atosiban.</strong> Peptide analogue. Competitively blocks oxytocin receptors.
                                Fewer cardiovascular side effects. Used in Europe.</p>

                            <h3>4. Magnesium Sulfate</h3>
                            <p>Competes with Calcium. Also used for eclampsia. Not recommended now for tocolysis due to
                                higher perinatal mortality risk.</p>
                        </div>
                    </section>

                    <!-- Section 7: Case Study -->
                    <section class="content-section" id="case-study">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§î</span>
                                Problem Directed Study
                            </h2>
                        </div>

                        <div class="content-card">
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <h4 class="callout-title">Case 23.1</h4>
                                </div>
                                <div class="callout-content">
                                    <p>A full term primigravida aged 26 years presented with labour pains for 24 hours
                                        (prolonged labour). Passed meconium stained liquor 2 hours ago (Indicator of
                                        <strong>foetal distress</strong>). Patient is distressed. Head engaged but
                                        cervix incompletely dilated. Uterine contractions weak.</p>
                                    <p><strong>(a) Action:</strong> The presence of <strong>foetal distress</strong>
                                        (meconium staining, tachycardia/irregularity) along with uterine inertia and
                                        maternal exhaustion usually calls for expedited delivery, often by
                                        <strong>Caesarean section</strong>, rather than stimulation of labour.</p>
                                    <p><strong>(b) Use of Stimulant:</strong> <strong>NO</strong>. Administration of a
                                        uterine stimulant like Oxytocin is generally <strong>contraindicated in the
                                            presence of foetal distress</strong> because strengthening contractions
                                        further reduces placental blood flow, worsening foetal hypoxia and potentially
                                        causing foetal death or uterine rupture. Oxytocin should only be used when
                                        foetal condition is satisfactory.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="topic-23-estrogens.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Estrogens & Contraceptives</div>
                        </a>

                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>24</span>
                                <span class="progress-separator">/</span>
                                <span>27</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 88%;"></div>
                            </div>
                            <div class="progress-label">Topic Progress</div>
                        </div>

                        <a href="topic-25-calcium.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Calcium & Bone Drugs</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="../js/theme.js"></script>

    <script src="../js/navigation.js"></script>

    <script src="../js/interactions.js"></script>

</body>

</html>